EquityZen Growth Technology Fund LLC - Series 141
Raised
$371K
Investors
8
Min Invest
$10,000
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 141 is a Delaware-organized pooled investment fund filed by EquityZen Advisors LLC on 2017-09-05, raising $371K from 8 investors with a $10K minimum investment under Rule 506(b) and Section 3(c)(1). This entity is part of the EquityZen platform, which operates nearly 1,900 related EDGAR entities focused on pre-IPO secondary transactions.
This pre-IPO pooled fund uses the standard 506(b)/3(c)(1) exemption structure common to platforms facilitating secondary market access to private company shares. The $10K minimum represents a relatively accessible entry point for accredited investors compared to traditional pre-IPO funds, which often require six-figure commitments.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Erin Rosenthal
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Shiraram Bhashyam
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.